On August 20, ScanSource (NASDAQ:SCSC) reported fourth-quarter results that included a record non-GAAP profit and revealed a $220.5 million deal to acquire MicroAge. Net sales climbed 17.3% year over year to $953.1 million, and non-GAAP diluted earnings per share jumped 43.1% to $1.46. Management framed the results as a shift from playing defense to actively pursuing market share, a notable change in tone for a distributor that spent years fighting just to hold its ground.
Hardware Demand Comes Roaring Back
The quarter’s growth wasn’t confined to one corner of the business. Specialty Technology Solutions, ScanSource’s hardware distribution segment, generated $927.2 million in net sales, up 17.6% year over year on demand for physical security, mobility, and networking gear. Segment adjusted EBITDA rose 28% to $36.7 million. The Intelisys and Advisory segment, which sells cloud and connectivity services through the channel, added $25.9 million in quarterly revenue, up 7.2% on higher Resourcive sales, and net billings for the full fiscal year reached $2.88 billion.
Recurring revenue is becoming a bigger part of the story. It grew 10.6% for the fiscal year to $161.2 million and now makes up 33.7% of consolidated gross profit, a mix shift that tends to smooth out the lumpiness of hardware sales. The pending MicroAge acquisition, an all-cash purchase expected to close by the end of the first quarter of fiscal 2027, pushes further in that direction, adding cloud migration, cybersecurity, and AI implementation services that ScanSource’s channel partners have historically had to source elsewhere. Many solution providers cannot pair a security sale with the ongoing implementation and support it requires, and that gap is what MicroAge is meant to close.
The balance sheet backs up the growth. ScanSource generated $113.8 million in free cash flow for the year, a 124% conversion of non-GAAP net income, while net debt leverage sat at roughly zero relative to trailing 12-month adjusted EBITDA. The company still bought back $97.9 million in stock during the year and has about $121 million left under its current authorization.
Brazil And Networking Hit Snags
Not every region moved in the same direction. Net sales in Brazil fell 21.6% year over year to $53.5 million in the quarter, and the company said it had to reduce headcount there to protect profitability. The unit stayed profitable, but a double-digit sales decline in an international market isn’t a small item to write off.
Networking carries its own friction. Supply constraints tied to Juniper are expected to slow partner opportunities in the first half of fiscal 2027, even though most of the technology portfolio should see normal lead times. That’s a reminder that ScanSource’s growth still depends on getting physical product from vendors to partners on schedule.
The fiscal 2027 outlook also leans on an assumption that hasn’t fully played out. CFO Steve Jones said the guidance for 6% to 10% organic revenue growth assumes the return of the large-scale technology deployments seen in the back half of fiscal 2026, and he acknowledged that a macro environment outside the company’s control remains a real variable. On top of that, the Specialty Technology Solutions segment, which drives most of ScanSource’s revenue, runs on a thin 3.96% adjusted EBITDA margin, a reminder of how little cushion hardware distribution carries even in a strong quarter.
What The Smart Money Sees
Hedge fund ownership of ScanSource climbed from 16 funds in the prior quarter to 20 in the most recent one, a sign that institutional interest is building rather than fading. Short interest sits at 7.63% of the float, enough to show real skepticism without pointing to a crowded short trade. Meanwhile, the stock trades at a forward price-to-earnings ratio of just 11.85 as of August 28, a multiple that doesn’t appear to price in much of the growth acceleration management is now guiding toward.
The Next Chapter Is Unwritten
ScanSource closed out fiscal 2026, the year ended June 30, 2026, with its strongest quarter in some time and a plan to reshape itself through the MicroAge deal. The bulls can point to record earnings, growing recurring revenue, and a balance sheet clean enough to keep funding buybacks. The bears can point to Brazil’s decline, supply constraints in networking, and a fiscal 2027 outlook that depends on large deals repeating themselves.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Disclosure: None. Follow Insider Monkey on Google News.
